Nutra Pharma Corp Stock Volatility
| NPHC Stock | USD 0.0002 0.00 0.00% |
Nutra Pharma is out of control given 3 months investment horizon. Nutra Pharma Corp has Sharpe Ratio of 0.19, which conveys that the firm had a 0.19 % return per unit of risk over the last 3 months. We have analyze and collected data for sixteen different technical indicators, which can help you to evaluate if expected returns of 37.04% are justified by taking the suggested risk. Use Nutra Pharma Corp Mean Deviation of 2.98, risk adjusted performance of 0.1185, and Standard Deviation of 12.31 to evaluate company specific risk that cannot be diversified away. Key indicators related to Nutra Pharma's volatility include:
90 Days Market Risk | Chance Of Distress | 90 Days Economic Sensitivity |
Nutra Pharma Pink Sheet volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Nutra daily returns, and it is calculated using variance and standard deviation. We also use Nutra's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Nutra Pharma volatility.
Nutra |
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as Nutra Pharma can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game as hey may decide to buy additional stocks of Nutra Pharma at lower prices to lower their average cost per share. Similarly, when the prices of Nutra Pharma's stock rise, investors can sell out and invest the proceeds in other equities with better opportunities.
Moving against Nutra Pink Sheet
| 0.45 | AXP | American Express | PairCorr |
| 0.42 | QLGN | Qualigen Therapeutics | PairCorr |
| 0.41 | HD | Home Depot | PairCorr |
| 0.41 | CAT | Caterpillar | PairCorr |
| 0.33 | ASTI | Ascent Solar Technol | PairCorr |
Nutra Pharma Market Sensitivity And Downside Risk
Nutra Pharma's beta coefficient measures the volatility of Nutra pink sheet compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Nutra pink sheet's returns against your selected market. In other words, Nutra Pharma's beta of 1.79 provides an investor with an approximation of how much risk Nutra Pharma pink sheet can potentially add to one of your existing portfolios. Nutra Pharma Corp is displaying above-average volatility over the selected time horizon. Nutra Pharma Corp appears to be a penny stock. Although Nutra Pharma Corp may be, in fact, a solid short-term or long term investment, many penny pink sheets are speculative investment instruments that are often subject to artificial stock promotion and campaigns of hype which may lead to misinformation and misrepresentation. Please make sure you fully understand upside potential and downside risks of investing in Nutra Pharma Corp or similar risky assets. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswing without any event/news,and sudden news releases. We also encourage traders to check biographies and work history of company President, CEO or other officers before investing in high-volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Nutra instrument if you perfectly time your entry and exit. However, remember that penny pink sheets that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.
3 Months Beta |Analyze Nutra Pharma Corp Demand TrendCheck current 90 days Nutra Pharma correlation with market (Dow Jones Industrial)Nutra Beta |
Nutra standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.
Standard Deviation | 194.44 |
It is essential to understand the difference between upside risk (as represented by Nutra Pharma's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of Nutra Pharma's daily returns or price. Since the actual investment returns on holding a position in nutra pink sheet tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in Nutra Pharma.
Nutra Pharma Corp Pink Sheet Volatility Analysis
Volatility refers to the frequency at which Nutra Pharma pink sheet price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Nutra Pharma's price changes. Investors will then calculate the volatility of Nutra Pharma's pink sheet to predict their future moves. A pink sheet that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A pink sheet with relatively stable price changes has low volatility. A highly volatile pink sheet is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Nutra Pharma's volatility:
Historical Volatility
This type of pink sheet volatility measures Nutra Pharma's fluctuations based on previous trends. It's commonly used to predict Nutra Pharma's future behavior based on its past. However, it cannot conclusively determine the future direction of the pink sheet.Implied Volatility
This type of volatility provides a positive outlook on future price fluctuations for Nutra Pharma's current market price. This means that the pink sheet will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Nutra Pharma's to be redeemed at a future date.Transformation |
We are not able to run technical analysis function on this symbol. We either do not have that equity or its historical data is not available at this time. Please try again later.
Nutra Pharma Projected Return Density Against Market
Given the investment horizon of 90 days the pink sheet has the beta coefficient of 1.7924 . This indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Nutra Pharma will likely underperform.Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Nutra Pharma or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Nutra Pharma's price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Nutra pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Nutra Pharma Corp has an alpha of 1.6394, implying that it can generate a 1.64 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Predicted Return Density |
| Returns |
What Drives a Nutra Pharma Price Volatility?
Several factors can influence a pink sheet's market volatility:Industry
Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.Political and Economic environment
When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.The Company's Performance
Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.Nutra Pharma Pink Sheet Risk Measures
Given the investment horizon of 90 days the coefficient of variation of Nutra Pharma is 524.98. The daily returns are distributed with a variance of 37806.27 and standard deviation of 194.44. The mean deviation of Nutra Pharma Corp is currently at 75.99. For similar time horizon, the selected benchmark (Dow Jones Industrial) has volatility of 0.89
α | Alpha over Dow Jones | 1.64 | |
β | Beta against Dow Jones | 1.79 | |
σ | Overall volatility | 194.44 | |
Ir | Information ratio | 0.13 |
Nutra Pharma Pink Sheet Return Volatility
Nutra Pharma historical daily return volatility represents how much of Nutra Pharma pink sheet's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The firm inherits 194.4383% risk (volatility on return distribution) over the 90 days horizon. By contrast, Dow Jones Industrial accepts 0.8516% volatility on return distribution over the 90 days horizon. Performance |
| Timeline |
About Nutra Pharma Volatility
Volatility is a rate at which the price of Nutra Pharma or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Nutra Pharma may increase or decrease. In other words, similar to Nutra's beta indicator, it measures the risk of Nutra Pharma and helps estimate the fluctuations that may happen in a short period of time. So if prices of Nutra Pharma fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.Nutra Pharma Corp., a biopharmaceutical company, acquires, licenses, and commercializes pharmaceutical products and technologies, and homeopathic and ethical drugs for the management of pain, neurological disorders, cancer, and autoimmune and infectious diseases primarily in the United States. The company was incorporated in 2000 and is based in Plantation, Florida. NUTRA PHARMA operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 4 people.
Nutra Pharma's stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on Nutra Pink Sheet over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much Nutra Pharma's price varies over time.
3 ways to utilize Nutra Pharma's volatility to invest better
Higher Nutra Pharma's stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of Nutra Pharma Corp stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. Nutra Pharma Corp stock volatility can provide helpful information for making investment decisions in the following ways:- Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of Nutra Pharma Corp investment. A higher volatility means higher risk and potentially larger changes in value.
- Identifying Opportunities: High volatility in Nutra Pharma's stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
- Diversification: Understanding how the volatility of Nutra Pharma's stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
Nutra Pharma Investment Opportunity
Nutra Pharma Corp has a volatility of 194.44 and is 228.75 times more volatile than Dow Jones Industrial. 96 percent of all equities and portfolios are less risky than Nutra Pharma. You can use Nutra Pharma Corp to protect your portfolios against small market fluctuations. The pink sheet experiences a normal downward fluctuation but is a risky buy. Check odds of Nutra Pharma to be traded at $2.0E-4 in 90 days.Average diversification
The correlation between Nutra Pharma Corp and DJI is 0.13 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Nutra Pharma Corp and DJI in the same portfolio, assuming nothing else is changed.
Nutra Pharma Additional Risk Indicators
The analysis of Nutra Pharma's secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Nutra Pharma's investment and either accepting that risk or mitigating it. Along with some common measures of Nutra Pharma pink sheet's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Risk Adjusted Performance | 0.1185 | |||
| Market Risk Adjusted Performance | 0.8497 | |||
| Mean Deviation | 2.98 | |||
| Coefficient Of Variation | 812.4 | |||
| Standard Deviation | 12.31 | |||
| Variance | 151.52 | |||
| Information Ratio | 0.1284 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential pink sheets, we recommend comparing similar pink sheets with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Nutra Pharma Suggested Diversification Pairs
Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Nutra Pharma as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Nutra Pharma's systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Nutra Pharma's unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Nutra Pharma Corp.
Complementary Tools for Nutra Pink Sheet analysis
When running Nutra Pharma's price analysis, check to measure Nutra Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nutra Pharma is operating at the current time. Most of Nutra Pharma's value examination focuses on studying past and present price action to predict the probability of Nutra Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nutra Pharma's price. Additionally, you may evaluate how the addition of Nutra Pharma to your portfolios can decrease your overall portfolio volatility.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |